Antimicrobial resistance (AMR) is a global public health threat. Every year, a growing number of bacteria, viruses, fungi, and parasites become resistant to existing medications, making common infections harder to treat and increasing the risk of disease transmission,...
Senior Pauline was one of only three midwives on duty the night that Ankunda Teddy arrived at the Mubende Regional Referral Hospital in distress. The 28-year-old had been in labor for over 12 hours when she was referred to the hospital by a traditional birth...
Previously Chief Financial Officer for Allergan India, Middle East & Africa (IMEA) Experience in multiple industries, including pharmaceuticals and telecommunication Nov. 17, 2020 – The Clinton Health Access Initiative (CHAI) is pleased to announce the appointment...
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI. Please tell us a bit about your background and what brought you to CHAI. My name is Prudence Michel Haimbe. I am based in Zambia. I joined CHAI in November 2012. In...
LONDON/ NEW YORK, Nov. 11, 2020 – Severe pneumonia leaves an estimated 4.2 million children under the age of five in 124 low- and middle-income countries with critically low oxygen levels each year, new analysis from UNICEF, Clinton Health Access Initiative (CHAI),...
During Breast Cancer Awareness Month, it is important to remember that about 60 percent of breast cancer cases occur in low- and middle-income countries, where breast cancer is roughly 64 percent more deadly for women due to challenges in accessing quality...
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI. Gracias a Dios Associate, Global Malaria Honduras Start date: Oct. 23, 2017 Please tell us a bit about your background and what brought you to CHAI. I am a medical...
Cardiovascular disease is the world’s biggest killer, claiming 17.7 million lives every year. Eighty percent of all cardiovascular deaths are from heart attacks and strokes, and 75 percent of those occur in low- and middle-income countries. As we make progress in the...
A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low- and middle-income countries, catalytic funding to assist governments to deploy the tests, and an initial US$50M...
